![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » AstraZeneca to Manufacture Oxford University’s COVID-19 Vaccine
AstraZeneca to Manufacture Oxford University’s COVID-19 Vaccine
![AstraZeneca](https://www.fdanews.com/ext/resources/test/Device_Images2/AstraZeneca.gif?t=1576126438&width=430)
AstraZeneca has entered into an agreement with Oxford University to develop and distribute Oxford’s COVID-19 vaccine.
If clinical trials show that the vaccine is effective, AstraZeneca will lead the development, worldwide manufacturing and distribution of the vaccine.
The vaccine candidate entered phase 1 trials last week in healthy volunteers aged 18 to 55 across five centers in southern England.
Upcoming Events
-
21Oct